A Phase I Study of JSKN021 in Advanced Solid Tumors
A Phase I Study of JSKN021 in Advanced Solid Tumors
Recruiting · NCT07617727 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase I Study of JSKN021 in Advanced Solid Tumors | Advanced Malignant Solid Tumors | Recruiting | Phase 1 | 2026-08-26 | NCT07617727 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Jiangsu Alphamab Biopharmaceuticals Co., Ltd | 17 |
10 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Affiliated Hospital of Jining Medical College | Jining | China | 5 |
| Fudan University Shanghai Cancer Center | Shanghai | China | 85 |
| Fujian Cancer Hospital | Fuzhou | China | 109 |
| Harbin Medical University Cancer Hospital | Harbin | China | 102 |
| Hubei Cancer Hospital | Wuhan | China | 95 |
| Jiangsu Province Hospital | Nanjing | China | 37 |
| Tianjin Medical University Cancer Institute & Hospital | Tianjin | China | 58 |
| Tumor Hospital of Guangxi Medical University | Nanning | China | 1 |
| Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Wuhan | China | 54 |
| Xuzhou Central Hospital | Xuzhou | China | 23 |